An international study linking the use of strong cannabis to psychotic illnesses such as schizophrenia has raised concerns about moves in the US and elsewhere to decriminalise the drug. Katie Martin discusses the findings with Clive Cookson, FT science editor, and psychiatrist Robin Murray. Read Clive's article here. Read the research paper here


Contributors: Suzanne Blumsom, executive editor, Katie Martin, capital markets editor, Clive Cookson, science editor, and Robin Murray, professor of psychiatric research at Kings College in London. Producer: Fiona Symon


A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on News in Focus when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast